Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

CLS secures new leases at The Coade, Vauxhall

(Sharecast News) - Commercial property investor CLS said on Thursday that it has secured over 8,000 square feet of new leases at its newly developed office building in the heart of Vauxhall, The Coade. CLS said The Coade continues to attract "a diverse mix of occupiers", with three new leases agreed.

In May, National Skills Academy for Rail, a rail consulting company, signed a five-year lease for 1,862 square feet on the first floor. Since July, accountancy and professional advice firm Wellers signed a 10-year lease for 3,090 square feet on the third floor, and CLS also agreed heads of terms with an unnamed business-to-business media company for a five-year lease for 3,088 square feet on the second floor.

CLS noted that the leases were signed at an average of £48 per square foot, in line with the latest estimated rental values.

Chief executive Fredrik Widlund said: "We are very excited to welcome the new tenants to The Coade. Their arrival highlights both the quality of our development and the continued appeal of Vauxhall as a business destination. The Coade is a stunning addition to Vauxhall, attracting a diverse and growing mix of tenants who are drawn to its design, sustainability credentials, and central location."

As of 0920 BST, CLS shares were up 0.31% at 65p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.